Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 5, 2007 - Javelin Pharmaceuticals, Inc. (AMEX: JAV), a leading developer of novel products for pain control, today announced that its Phase 2 multi-dose study of Rylomine was published in Pain Medicine, the official journal of The American Academy of Pain Medi...Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial Data
...fter elective orthopedic surgery were given 7.5 mg rylomine every hour as needed, 15 mg rylomine every 3 hours as needed, or 7.5 mg intravenous (IV...end our prior positive study findings showing that rylomine is a simple, effective alternative to more complex...News - Javelin's Positive Intranasal Morphine Phase 2 Clinical Trial ...
Javelin's Positive Intranasal Morphine Phase 2 Clinical Trial Data Presented at ... Unlike IV morphine, Rylomine offers patients the ability to self-administer ...Summary of JAVELIN PHARMACEUTICALS, INC - Yahoo! Finance
... sodium injectable), Rylomine(TM) (intranasal morphine) and PMI-100/150 (intranasal ketamine) ... include the development of Dyloject(TM), Rylomine(TM) and ...Summary of JAVELIN PHARMACEUTICALS, INC - Yahoo! Finance
... the manufacture of drug supply for Rylomine_ clinical trials. ... costs increased by $64,286 associated with preparation for the Rylomine ...PipelineReview.com - Biotech News & Online Store - Javelin's Positive ...
PipelineReview.com is the Biotech News Center and Online Store of La Merie Business Intelligence focused on Research and ... IV morphine, Rylomine(TM) offers ...Javelin Pharmaceuticals - Javelin Pharmaceuticals - Overview
Corporate site of Javelin Pharmaceuticals, Inc. formerly IDDS, Inc.; a New York -based specialty pharmaceutical ... and Rylomine™ (intranasal morphine) ...